H.R. 8667: Maximizing Individual Savings for Servicemembers In Obtaining Negotiated Rx Act

This bill, known as the MISSION Rx Act, seeks to amend certain provisions in U.S. law to establish maximum cost-sharing amounts for prescription drugs for servicemembers and veterans. Here’s a breakdown of what the bill proposes:

Cost-Sharing Limits for Selected Drugs

The bill amends the TRICARE program, which provides healthcare to military members, retirees, and their families, as well as benefits for veterans. Specifically, it sets limits on how much these eligible individuals would need to pay out-of-pocket for certain selected drugs, as identified under a wider drug price negotiation program established by the Social Security Act.

• For any selected drug, the annual cost-sharing amount for a TRICARE beneficiary would not exceed what a Medicare beneficiary pays for the same drug under Medicare Part D.
• Similarly, veterans would have their copayment amounts capped at the level set for Medicare beneficiaries under the same conditions.

Definitions of Selected Drugs

The bill clarifies what constitutes a "selected drug" by referring to the definition found in section 1192 of the Social Security Act. This is crucial for determining which drugs are eligible for the price negotiation and cost-sharing provisions outlined in the bill.

Drug Price Procurement by Federal Agencies

The bill also impacts how Federal agencies procure drugs. It mandates that the maximum price for selected drugs can only be set at rates determined by the Drug Price Negotiation Program. This means:

• Manufacturers of selected drugs cannot set prices higher than those negotiated through this program for federal procurement.
• This pricing framework aims to stabilize and potentially lower costs for the federal government in purchasing medications for these programs.

Implementation and Modifications

The amendments made by this bill would apply to all agreements related to the purchase of selected drugs that are in effect when the bill is enacted or enter into force afterward. If the Drug Price Negotiation Program is terminated, the bill mandates that agreements must be modified to reflect maximum drug prices in line with prior laws.

Overall Intent

The overarching goal of the MISSION Rx Act is to reduce prescription drug costs for servicemembers and veterans, ensuring that their copayment amounts are manageable and equitable compared to those paid by Medicare beneficiaries.

Relevant Companies

• PFE (Pfizer Inc.): As a major pharmaceutical company, changes in pricing regulations could impact how much they can charge federal agencies for selected drugs.
• BMY (Bristol Myers Squibb Co.): Similarly, this company may need to adjust pricing strategies due to the set pricing caps on selected drugs.
• AMGN (Amgen Inc.): As one of the manufacturers that could be involved in selling selected drugs to veterans and the government, their sales could be affected by the new cost-sharing limits.